![](/img/cover-not-exists.png)
Single Therapeutic and Supratherapeutic Doses of Laropiprant, a Selective Prostaglandin D 2 Receptor 1 Antagonist, Do Not Prolong the QTcF Interval in Healthy Volunteers
Luo, Wen-Lin, Crumley, Tami, Ebel, David, Atiee, George J., Royalty, Jane, Johnson-Levonas, Amy O., Wagner, John, Lai, EsengVolume:
50
Language:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1177/0091270009360042
Date:
November, 2010
File:
PDF, 132 KB
english, 2010